At Cellmig, we are developing next generation medicines for cancer patients
Cellmig is a global biopharmaceutical company focused on cutting-edge biomedical technologies for cancer metastasis care. Our pioneer discoveries, technologies and science allow us to develop life-changing medicines and medical devices. It is our commitment objective to end cancer death and save lives of all cancer patients worldwide.
Cellmig unveils the physical membranous cancer cell dissemination pathways of Cytocapsular Tubes in clinical cancer patients. This revolutionary discovery is fundamental and essential for cancer metastasis therapy and treatment. It may enable both quantitative analysis of cancer metastasis and the precise identification of the cancer metastasis margin and status in micrometer level.
We are developing next generation medicines specifically designed to effectively inhibit cancer cell dissemination, eliminate cancer, and terminate cancer lethality, and therefore increase the longevity and quality of life of all cancer patients around the world.
